ReviewAnnals of biomedical engineering2026
Neural Vision Restoration in Ophthalmology.
Review in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neural vision restoration is a rapidly advancing discipline at the intersection of neuroscience, bioengineering, and ophthalmology. This review synthesizes emerging strategies to restore visual perception through retinal prostheses, optic nerve and thalamic implants, cortical brain-computer interfaces (BCIs), optogenetics, and non-invasive stimulation. Although initial experiments have demonstrated primitive visual abilities such as light perception and motion detection, artificial vision remains cognitively demanding and fundamentally different from natural vision. Advances in artificial intelligence and machine learning may enable adaptive, closed-loop systems that optimize stimulation, enhance low-light vision, and integrate environmental inputs for more intelligible percepts. At the same time, a growing understanding of neural plasticity, cortical remapping, and perceptual learning highlights the need for multidisciplinary strategies in visual rehabilitation. Ethical and regulatory concerns, including informed consent, data protection, neural enhancement, and equitable access, remain central to responsible implementation. The potential of BCIs to bypass the eye entirely, and of neuroprosthetics to be used in spaceflight, disaster response, or military medicine, expands the applications of vision restoration beyond blindness alone. Bridging technological, clinical, and ethical strategies in this review outlines the challenges and opportunities that define the future of neural ophthalmology. Ultimately, restoring sight will require not only functioning hardware, but systems compatible with the reorganized brain and the lived experience of visual loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.